Atlas Trials

Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

Clinical trial NCT01510028 · COMPLETED

Trial details

NCT number
NCT01510028
Sponsor
Shire
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metachromatic Leukodystrophy (MLD)
Start date
2012-02-02
Primary completion
2017-01-20
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.